ustekinumab - Stelara; CNTO 1275; interleukin-12 (IL-12) and interleukin-23 (IL-23) p40 subunit monoclonal antibody, human, recombinant -- Product Record

IL-12/23 Mab, rDNA/J&J

    Nomenclature:
      IL-12/23 Mab, rDNA/J&J [BIO]
      Ustekinumab [USAN; INN]
      Immunoglobulin G1, anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 gamma1-chain), disulfide with human monoclonal CNTO 1275 kappa-chain, dimer [CAS]
      Immunoglobulin G1, anti-(human interleukin-12 subunit beta (IL-12B, CLMF p40, NKSF2)) (human monoclonal CNTO 1275 gamma1-chain), disulfide with human monoclonal CNTO 1275 kappa-chain, dimer [CAS]
      815610-63-0 [CAS RN]
      12B75 [SY]
      anti-IL-12/IL-23 antibody [SY]
      CNTO 1275 [SY]
      CNTO-1275 [SY]
      interleukin-12 (IL-12) and interleukin-23 (IL-23) p40 subunit monoclonal antibody, human, recombinant [SY]
      Stelara [TR in Europe]
      57894-060-03; 57894-061-03; 57894-060-02; 57894-061-02 [NDC]

    molecular weight (kDa) = 145.65

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 2009